Literature DB >> 7667823

Sensitivity to activated protein C; influence of oral contraceptives and sex.

C M Henkens1, V J Bom, A J Seinen, J van der Meer.   

Abstract

We investigated sensitivity to activated protein C (APC) in 43 men, 42 women not using oral contraceptives (OC) and 38 women using OC containing 30.0-37.5 micrograms ethinyl estradiol. A commercially available kit was used. Men were more sensitive to APC as compared with women not using OC (p < 0.005), but this difference seems not to be of clinical importance. Women using OC showed to be significantly less sensitive to APC, reflected by a lower APC-ratio, as compared with men (p < 0.005) and women not using OC (p < 0.05). So, in normal individuals the APC-sensitivity differs according to sex and estrogen intake. This should be taken into account when interpreting APC-ratios.

Entities:  

Keywords:  Biology; Blood Coagulation Effects; Blood Proteins; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Methods; Demographic Factors; Ethinyl Estradiol; Family Planning; Hematological Effects; Hemic System; Oral Contraceptives; Physiology; Population; Population Characteristics; Research Methodology; Research Report; Sex Factors; Studies

Mesh:

Substances:

Year:  1995        PMID: 7667823

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Incidence of factor V Leiden in patients with acute myocardial infarction.

Authors:  M S Gowda; M L Zucker; J L Vacek; W L Carriger; D L Van Laeys; J M Rachel; B D Strope
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

Review 2.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

3.  Interlaboratory variability of activated protein C resistance using the ETP-based APC resistance assay.

Authors:  Laure Morimont; Marie Didembourg; Hélène Haguet; Élise Modaffari; Maxence Tillier; Céline Bouvy; Aurélien Lebreton; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Res Pract Thromb Haemost       Date:  2021-11-02

4.  Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia system.

Authors:  Laure Morimont; Charline Leclercq; Marie Didembourg; Émilie De Gottal; Audrey Carlo; Ulysse Gaspard; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Res Pract Thromb Haemost       Date:  2022-04-07

Review 5.  Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.

Authors:  Laure Morimont; Hélène Haguet; Jean-Michel Dogné; Ulysse Gaspard; Jonathan Douxfils
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.